Home › Sclerosing Cholangitis › Pennsylvania
Sclerosing Cholangitis clinical trials in Pennsylvania
3 studies for Sclerosing Cholangitis are looking for participants at sites in Pennsylvania.
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
- Penn State Milton S.Hershey Medical Center - Penn State Hershey Cancer Institute, Hershey
- University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University Hospital - Jefferson Digestive Disease Institute (JDDI), Philadelphia
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 1, 2026 · NCT07387549A-LiNK: Improving Outcomes in Autoimmune Liver Disease
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
RecruitingObservational study
All ages · All sexes · Updated Aug 19, 2026 · NCT05750498Primary Sclerosing Cholangitis in Children
- The Children's Hospital of Philadelphia, Philadelphia
RecruitingObservational study
Ages 2 to 25 · All sexes · Updated Jul 14, 2026 · NCT04181138From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.